10:16:21 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Aurora Cannabis Inc
Symbol ACB
Shares Issued 1,168,189,723
Close 2020-02-10 C$ 2.08
Market Cap C$ 2,429,834,624
Recent Sedar Documents

Aurora Cannabis to release Q2 FY 2020 results Feb. 13

2020-02-10 17:41 ET - News Release

Mr. Michael Singer reports

AURORA CANNABIS TO HOST SECOND QUARTER 2020 INVESTOR CONFERENCE CALL

Aurora Cannabis Inc. has scheduled a conference call to discuss the results for its second quarter ended Dec. 31, 2019, on Feb. 13, 2020, at 8 a.m. Eastern Time. Michael Singer, interim chief executive officer and executive chairman, and Glen Ibbott, chief financial officer, will host the call and a question-and-answer period. The company will release its financial results for the second quarter before the open of markets on Feb. 13, 2020.

Conference call details

Date:  Feb. 13, 2020

Time:  8 a.m. Eastern Time or 6 a.m. Mountain Time

Replay:  844-512-2921 or 412-317-6671 available until 11:59 p.m. Eastern Time on Feb. 27, 2020

PIN:  13699134

About Aurora Cannabis Inc.

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's presence spans 25 countries across five continents with a brand portfolio that includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Roar Sports. Providing customers with innovative, high-quality cannabis and hemp products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.